Ativa Medical: LabCorp, China's Fosun Pharma, lead Asia-heavy $15B investment in Ativa Medical
LabCorp and China's Fosun Pharma are among the investors in a $15B Series B round that funds Ativa Medical's point-of-care diagnostics technology.
Read full article »
Ativa Medical is a medical diagnostics company that develops and commercializes point-of-care systems for chemistry and hematology testing.
Read more